Item 7.01 Regulation FD Disclosure. On July 1, 2022, Intercept Pharmaceuticals, Inc. (“Intercept”) issued a press release announcing the closing of its previously announced transaction with Advanz Pharma. A copy of the press release is attached as Exhibit 99.1 and incorporated by reference. Intercept will follow with a further Current Report on Form 8-K containing the disclosures required by Items 2.01 and 9.01(b) of Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued July 1, 2022 104 Cover Page Interactive Data File (embedded as Inline XBRL document) The information in Item 7.01 and Exhibit 99.1 is being furnished, not fi(…)
The Latest Press Releases